Padcev (enfortumab vedotin-ejfv) - Astellas, Pfizer
Keytruda (pembrolizumab) - Merck (MSD)
https://www.ema.europa.eu/en/documents/minutes/minutes-chmp-meeting-23-26-february-2026_en.pdf
 
Aug 30, 2026
 
Prev Next